| Therapy Category | Chemotherapy, Alkylating Agent |
|---|---|
| Protocols/Regimens | Bendamustine + Rituximab (Br), Bendamustine-Based Lymphoma Regimens |
| Primary Indications | Indolent B-Cell Non-Hodgkin Lymphomas, Cll, Other Selected Lymphoid Malignancies |
| Cancer/Tumor Types | Nhl, Cll, Sll |
| Salt / Active Composition | BENDAMUSTINE |
| Strength / Dosage | 100 |
| Dosage Form | Injection |
| Prescription Required | Yes |